Nephro Care India Limited (NSE:NEPHROCARE)
India
· Delayed Price · Currency is INR 86.65
+0.35 (0.41%)
At close: Apr 28, 2026
Nephro Care India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 761.59 | 460.31 | 272.31 | 170.93 | 34.24 | 18.25 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | - | Upgrade
|
| Revenue | 761.59 | 460.31 | 272.31 | 170.93 | 34.24 | 18.25 | Upgrade
|
| Revenue Growth (YoY) | 93.59% | 69.04% | 59.31% | 399.14% | 87.66% | 239.02% | Upgrade
|
| Cost of Revenue | 354.72 | 209.12 | 114.39 | 62.29 | 18.7 | 14.02 | Upgrade
|
| Gross Profit | 406.88 | 251.19 | 157.91 | 108.64 | 15.55 | 4.23 | Upgrade
|
| Selling, General & Admin | 14.48 | 28.96 | 12.58 | 9.51 | 3.87 | 1.08 | Upgrade
|
| Other Operating Expenses | 313.82 | 160.65 | 79.68 | 64.87 | 10.42 | 1.6 | Upgrade
|
| Operating Expenses | 373.48 | 214.21 | 97.53 | 82.23 | 15.41 | 2.81 | Upgrade
|
| Operating Income | 33.4 | 36.98 | 60.38 | 26.41 | 0.14 | 1.42 | Upgrade
|
| Interest Expense | -1.17 | -0.13 | -0.04 | -0.08 | -0.15 | -0.3 | Upgrade
|
| Interest & Investment Income | 0.54 | 1.56 | 0.01 | 0.01 | 0.02 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.36 | -0.92 | -0.73 | -0.57 | -0.02 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 37.13 | 37.49 | 59.63 | 25.77 | 0 | 1.18 | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.4 | 10.8 | 2.61 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.91 | - | - | - | Upgrade
|
| Pretax Income | 42.53 | 48.29 | 61.32 | 25.77 | 0 | 1.18 | Upgrade
|
| Income Tax Expense | 11.61 | 11.9 | 17.21 | 2.05 | 0.1 | 0.29 | Upgrade
|
| Net Income | 30.91 | 36.39 | 44.11 | 23.73 | -0.1 | 0.89 | Upgrade
|
| Net Income to Common | 30.91 | 36.39 | 44.11 | 23.73 | -0.1 | 0.89 | Upgrade
|
| Net Income Growth | -21.20% | -17.51% | 85.94% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 19 | 15 | 12 | 10 | 4 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 15 | 12 | 10 | 4 | 0 | Upgrade
|
| Shares Change (YoY) | 24.16% | 29.10% | 18.36% | 181.20% | 1678.08% | 0.01% | Upgrade
|
| EPS (Basic) | 1.61 | 2.38 | 3.73 | 2.37 | -0.03 | 4.43 | Upgrade
|
| EPS (Diluted) | 1.61 | 2.38 | 3.73 | 2.37 | -0.03 | 4.43 | Upgrade
|
| EPS Growth | -36.55% | -36.14% | 57.26% | - | - | - | Upgrade
|
| Free Cash Flow | - | -219.79 | -23.78 | 36.17 | -22.75 | 1.56 | Upgrade
|
| Free Cash Flow Per Share | - | -14.38 | -2.01 | 3.62 | -6.40 | 7.80 | Upgrade
|
| Gross Margin | 53.42% | 54.57% | 57.99% | 63.56% | 45.40% | 23.18% | Upgrade
|
| Operating Margin | 4.38% | 8.03% | 22.17% | 15.45% | 0.41% | 7.76% | Upgrade
|
| Profit Margin | 4.06% | 7.90% | 16.20% | 13.88% | -0.29% | 4.86% | Upgrade
|
| Free Cash Flow Margin | - | -47.75% | -8.73% | 21.16% | -66.44% | 8.55% | Upgrade
|
| EBITDA | 75.11 | 61.58 | 65.66 | 34.25 | 1.26 | 1.55 | Upgrade
|
| EBITDA Margin | 9.86% | 13.38% | 24.11% | 20.04% | 3.67% | 8.47% | Upgrade
|
| D&A For EBITDA | 41.71 | 24.6 | 5.28 | 7.84 | 1.11 | 0.13 | Upgrade
|
| EBIT | 33.4 | 36.98 | 60.38 | 26.41 | 0.14 | 1.42 | Upgrade
|
| EBIT Margin | 4.38% | 8.03% | 22.17% | 15.45% | 0.41% | 7.76% | Upgrade
|
| Effective Tax Rate | 27.30% | 24.65% | 28.06% | 7.94% | 5000.00% | 24.77% | Upgrade
|
| Revenue as Reported | 774.05 | 475.58 | 276.01 | 170.95 | 34.27 | 18.33 | Upgrade
|
| Advertising Expenses | - | 5.22 | 1.88 | 0.84 | 0.07 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.